Payer costs of patients diagnosed with epilepsy

Payer costs of patients diagnosed with epilepsy

عرض إصدارات أخرى (1)

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Griffiths, R
التنسيق:	Journal article
منشور في:	1999

مواد مشابهة

Payer costs of patients diagnosed with epilepsy.
حسب: Griffiths, R, وآخرون
منشور في: (1999)

Factors influencing third party payer costs for allogeneic BMT.
حسب: Griffiths, R, وآخرون
منشور في: (1993)

Pourquoi Payer ?
حسب: Mary Ann Bates, وآخرون
منشور في: (2012-01-01)

Single-Payer Health Care Reform: Cost Considerations in Maine
حسب: Daniel Bryant
منشور في: (2024-09-01)

Unreliable VAT payer
حسب: Vladimír Balcar
منشور في: (2021-06-01)

Impact of payer rejections and out-of-pocket costs on patient access to bempedoic acid therapy
حسب: Jimin Hwang, وآخرون
منشور في: (2025-03-01)

Patient and Payer Preferences for Additional Value Criteria
حسب: Ivett Jakab, وآخرون
منشور في: (2021-06-01)

The Payer and Patient Cost Burden of Open Breast Conserving Procedures Following Percutaneous Breast Biopsy
حسب: Chloe C Kimball, وآخرون
منشور في: (2018-06-01)

Cost of hospitalization for firearm injuries by firearm type, intent, and payer in the United States
حسب: Corinne Peek-Asa, وآخرون
منشور في: (2017-07-01)

Costs of Hip Fractures in Postmenopausal Women in Portugal: A Study from the Payer’s Perspective
حسب: Anabela Barcelos, وآخرون
منشور في: (2023-12-01)

Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective
حسب: Brian Murray, وآخرون
منشور في: (2023-01-01)

Payer plus pour étudier mieux ?
حسب: Sandrine Garcia
منشور في: (2008-11-01)

THE TAX ADVANTAGES OF INCOME TAX PAYERS
حسب: SUCIU GHEORGHE
منشور في: (2015-04-01)

An integrated valuation model for payer and investor
حسب: Mark Nuijten, وآخرون
منشور في: (2022-12-01)

Are payers treating orphan drugs differently?
حسب: Joshua P. Cohen, وآخرون
منشور في: (2014-01-01)

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective
حسب: Stuart Silverman, وآخرون
منشور في: (2015-01-01)

Incremental cost of premature birth – a public health care payer perspective from Hungary
حسب: Gábor Kovács, وآخرون
منشور في: (2023-06-01)

Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives
حسب: Mabel Aoun, وآخرون
منشور في: (2022-05-01)

The impact of price transparency and competition on hospital costs: a research on all-payer claims databases
حسب: Ahreum Han, وآخرون
منشور في: (2022-11-01)

Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population
حسب: Bartels-Peculis L, وآخرون
منشور في: (2020-06-01)

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
حسب: Irfan Cicin, وآخرون
منشور في: (2021-06-01)

Penal fiscal liability of bailiff as the VAT payer
حسب: Fabian Nalikowski
منشور في: (2016-03-01)

An Analysis of Psychosis Readmissions: Payer Class Differences
حسب: Haylei Lorca
منشور في: (2012-01-01)

Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspective
حسب: George Joseph, وآخرون
منشور في: (2021-09-01)

Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses.
حسب: Christopher Cai, وآخرون
منشور في: (2020-01-01)

COVID-19-associated costs and mortality in Germany: an incidence-based analysis from a payer’s perspective
حسب: Florian Brandt, وآخرون
منشور في: (2024-03-01)

Analysis of hospital and payer costs of care: aggressive warming versus routine warming in abdominal major surgery
حسب: Shujia Song, وآخرون
منشور في: (2023-11-01)

Correction: Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives
حسب: Mabel Aoun, وآخرون
منشور في: (2022-06-01)

Cost-Effectiveness Of The SQ® Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
حسب: Vogelberg C, وآخرون
منشور في: (2019-11-01)

The perspective of tax payers to electronic tax filing system /
حسب: 293078 See, Wern Sian, وآخرون
منشور في: (2007)

Challenges of Using NIK as a Tax Payer Identity
حسب: Titin Fachriah Nur, وآخرون
منشور في: (2022-12-01)

Prescription drug spending by payer: Implications for managed care
حسب: Yousef Chavehpour, وآخرون
منشور في: (2024-03-01)

COMPETITION AMONG PAYERS IN HEALTH CARE. THEORETICAL APPROACH
حسب: Anna Hnatyszyn-Dzikowska
منشور في: (2013-06-01)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
حسب: Epstein RS
منشور في: (2021-09-01)

Role of EEG in Diagnosing Abdominal Epilepsy Patients
حسب: Swati Sunil Jagtap, وآخرون
منشور في: (2018-12-01)

Costs of Assisted Home Dialysis: A Single-Payer Canadian Model From ManitobaPlain-Language Summary
حسب: Ryan J. Bamforth, وآخرون
منشور في: (2021-11-01)

The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective
حسب: Katia Iskandar, وآخرون
منشور في: (2021-05-01)

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
حسب: Baker CL, وآخرون
منشور في: (2018-07-01)

Implementing a Hybrid Model of Therapy is a Win for Therapists, Patients and Payers
حسب: Ben Galin
منشور في: (2024-01-01)

Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
حسب: Edmonds, T, وآخرون
منشور في: (2024)